Revealing IRAK1/4 as an Emerging Target to Override Adaptive Resistance Heme Malignancies

Time: 2:00 pm
day: Day One


  • Reviewing IRAK1/4 signal transduction in cancer cells to inform future development
  • Clarifying the involvement of IRAK1/4 kinase signaling in the development of
    adaptive resistance
  • Identifying activated forms of IRAK4 in MDS/AML patients to inform effective
    drug selection